Posterior reversible encephalopathy syndrome in children: its high prevalence and more extensive imaging findings.

PubWeight™: 1.19‹?› | Rank: Top 10%

🔗 View Article (PMID 16860188)

Published in Am J Kidney Dis on August 01, 2006

Authors

Kenji Ishikura1, Masahiro Ikeda, Yuko Hamasaki, Hiroshi Hataya, Seiichirou Shishido, Hiroshi Asanuma, Gen Nishimura, Ryugo Hiramoto, Masataka Honda

Author Affiliations

1: Department of Pediatric Nephrology, Pediatric Urology and Kidney Transplant, and Pediatric Radiology, Tokyo Metropolitan Kiyose Children's Hospital, Japan. ishikura@chp-kiyose-tokyo.jp

Articles citing this

Posterior reversible encephalopathy syndrome in the pediatric renal population. Pediatr Nephrol (2007) 1.40

Posterior reversible encephalopathy syndrome in children with kidney diseases. Pediatr Nephrol (2011) 1.18

Cyclosporine and steroid therapy in children with steroid-resistant nephrotic syndrome. Pediatr Nephrol (2009) 1.00

Thromboembolic complications in childhood nephrotic syndrome: a clinical profile. Clin Exp Nephrol (2013) 0.93

Clinical and radiological spectrum of posterior reversible encephalopathy syndrome: does age make a difference?--A retrospective comparison between adult and pediatric patients. PLoS One (2014) 0.92

Patterns in early diffusion-weighted MRI in children with haemolytic uraemic syndrome and CNS involvement. Eur Radiol (2011) 0.91

Calcineurin Inhibitors Associated Posterior Reversible Encephalopathy Syndrome in Solid Organ Transplantation: Report of 2 Cases and Literature Review. Medicine (Baltimore) (2016) 0.90

Age and gender may affect posterior reversible encephalopathy syndrome in renal disease. Pediatr Nephrol (2011) 0.89

Children with posterior reversible encephalopathy syndrome associated with atypical diffusion-weighted imaging and apparent diffusion coefficient. Clin Exp Nephrol (2010) 0.87

Systematic review of structural and functional neuroimaging findings in children and adults with CKD. Clin J Am Soc Nephrol (2013) 0.85

A case of tacrolimus-induced encephalopathy after kidney transplantation. Korean J Pediatr (2011) 0.82

Childhood posterior reversible encephalopathy syndrome: Magnetic resonance imaging findings with emphasis on increased leptomeningeal FLAIR signal. Neuroradiol J (2015) 0.78

A case of PRES in an active lupus nephritis patient after treatment of corticosteroid and cyclophosphamide. Rheumatol Int (2014) 0.77

Posterior reversible encephalopathy syndrome in minimal change disease. Indian J Nephrol (2012) 0.75

Posterior reversible encephalopathy syndrome (PRES) in a patient with late postpartum eclampsia. BMJ Case Rep (2014) 0.75

Posterior Reversible Encephalopathy Syndrome in Henoch-Schonlein Purpura and Hemolytic Uremic Syndrome. J Clin Med Res (2016) 0.75

Posterior Reversible Encephalopathy Syndrome during Recovery from Hypovolemic Acute Kidney Injury after Trauma; Case Report and Literature Review. Bull Emerg Trauma (2017) 0.75

Arterial blood pressure but not serum albumin concentration correlates with ADC ratio values in pediatric posterior reversible encephalopathy syndrome. Neuroradiology (2015) 0.75

Posterior reversible encephalopathy syndrome in children with kidney disease. Int Urol Nephrol (2017) 0.75

Articles by these authors

Nosology and classification of genetic skeletal disorders: 2010 revision. Am J Med Genet A (2011) 4.27

Cardiac hypertrophy is inhibited by antagonism of ADAM12 processing of HB-EGF: metalloproteinase inhibitors as a new therapy. Nat Med (2002) 3.74

Human atrial natriuretic peptide and nicorandil as adjuncts to reperfusion treatment for acute myocardial infarction (J-WIND): two randomised trials. Lancet (2007) 2.48

Impact of blockade of histamine H2 receptors on chronic heart failure revealed by retrospective and prospective randomized studies. J Am Coll Cardiol (2006) 2.44

Targeting of both mouse neuropilin-1 and neuropilin-2 genes severely impairs developmental yolk sac and embryonic angiogenesis. Proc Natl Acad Sci U S A (2002) 2.27

Establishment of sandwich ELISA for soluble alpha-Klotho measurement: Age-dependent change of soluble alpha-Klotho levels in healthy subjects. Biochem Biophys Res Commun (2010) 2.20

Deletions and epimutations affecting the human 14q32.2 imprinted region in individuals with paternal and maternal upd(14)-like phenotypes. Nat Genet (2008) 2.16

Genetic deficiency of tartrate-resistant acid phosphatase associated with skeletal dysplasia, cerebral calcifications and autoimmunity. Nat Genet (2011) 2.16

Cortical-Bone Fragility--Insights from sFRP4 Deficiency in Pyle's Disease. N Engl J Med (2016) 2.15

A Golgi-associated PDZ domain protein modulates cystic fibrosis transmembrane regulator plasma membrane expression. J Biol Chem (2001) 1.97

Metformin prevents progression of heart failure in dogs: role of AMP-activated protein kinase. Circulation (2009) 1.95

Renal disease in the elderly and the very elderly Japanese: analysis of the Japan Renal Biopsy Registry (J-RBR). Clin Exp Nephrol (2012) 1.95

Loss-of-function mutations of CHST14 in a new type of Ehlers-Danlos syndrome. Hum Mutat (2010) 1.83

Activation of adenosine A1 receptor attenuates cardiac hypertrophy and prevents heart failure in murine left ventricular pressure-overload model. Circ Res (2003) 1.82

Erythropoietin enhances neovascularization of ischemic myocardium and improves left ventricular dysfunction after myocardial infarction in dogs. J Am Coll Cardiol (2006) 1.74

AMPK controls the speed of microtubule polymerization and directional cell migration through CLIP-170 phosphorylation. Nat Cell Biol (2010) 1.72

Prolonged targeting of ischemic/reperfused myocardium by liposomal adenosine augments cardioprotection in rats. J Am Coll Cardiol (2009) 1.71

Pravastatin improves renal ischemia-reperfusion injury by inhibiting the mevalonate pathway. Kidney Int (2008) 1.67

Ablation of C/EBP homologous protein attenuates endoplasmic reticulum-mediated apoptosis and cardiac dysfunction induced by pressure overload. Circulation (2010) 1.63

Prospective 5-year follow-up of cyclosporine treatment in children with steroid-resistant nephrosis. Pediatr Nephrol (2013) 1.60

Erythropoietin just before reperfusion reduces both lethal arrhythmias and infarct size via the phosphatidylinositol-3 kinase-dependent pathway in canine hearts. Cardiovasc Drugs Ther (2005) 1.59

Aldosterone nongenomically worsens ischemia via protein kinase C-dependent pathways in hypoperfused canine hearts. Hypertension (2005) 1.53

Morbidity in children with frequently relapsing nephrosis: 10-year follow-up of a randomized controlled trial. Pediatr Nephrol (2014) 1.53

Cytochrome P450 oxidoreductase gene mutations and Antley-Bixler syndrome with abnormal genitalia and/or impaired steroidogenesis: molecular and clinical studies in 10 patients. J Clin Endocrinol Metab (2004) 1.51

Impact of adenosine receptor signaling and metabolism on pathophysiology in patients with chronic heart failure. Hypertens Res (2007) 1.49

Disruption of aquaporin-11 produces polycystic kidneys following vacuolization of the proximal tubule. Mol Cell Biol (2005) 1.48

Urinary neutrophil-gelatinase associated lipocalin is a potential noninvasive marker for renal scarring in patients with vesicoureteral reflux. J Urol (2010) 1.48

An infantile case of Hinman syndrome with severe acute renal failure. Clin Exp Nephrol (2008) 1.42

Abnormal glucose tolerance contributes to the progression of chronic heart failure in patients with dilated cardiomyopathy. Hypertens Res (2006) 1.42

Unexpectedly high prevalence of pretransplant abnormal glucose tolerance in pediatric kidney transplant recipients. Pediatr Transplant (2006) 1.41

Serum blood urea nitrogen and plasma brain natriuretic Peptide and low diastolic blood pressure predict cardiovascular morbidity and mortality following discharge in acute decompensated heart failure patients. Circ J (2012) 1.40

Superior mesenteric artery syndrome: risk factor for duodenal involvement in Henoch-Schönlein purpura. Pediatr Int (2011) 1.39

Vaginoplasty in the female exstrophy population: Outcomes and complications. J Pediatr Urol (2010) 1.38

Henoch-Schönlein purpura nephritis with nephrotic state in children: predictors of poor outcomes. Pediatr Nephrol (2011) 1.34

Depression of proteasome activities during the progression of cardiac dysfunction in pressure-overloaded heart of mice. Biochem Biophys Res Commun (2005) 1.33

Nucleotide-sugar transporter SLC35D1 is critical to chondroitin sulfate synthesis in cartilage and skeletal development in mouse and human. Nat Med (2007) 1.32

Age, gender, and body length effects on reference serum creatinine levels determined by an enzymatic method in Japanese children: a multicenter study. Clin Exp Nephrol (2011) 1.31

Echocardiographic assessment of LV hypertrophy and function in aortic-banded mice: necropsy validation. Am J Physiol Heart Circ Physiol (2002) 1.31

Steroid treatment for severe childhood IgA nephropathy: a randomized, controlled trial. Clin J Am Soc Nephrol (2006) 1.24

Nephrotic state as a risk factor for developing posterior reversible encephalopathy syndrome in paediatric patients with nephrotic syndrome. Nephrol Dial Transplant (2008) 1.21

Long-term stimulation of adenosine A2b receptors begun after myocardial infarction prevents cardiac remodeling in rats. Circulation (2006) 1.21

Toll-like receptor 4: a novel signaling pathway during renal fibrogenesis. J Surg Res (2009) 1.20

PKA rapidly enhances proteasome assembly and activity in in vivo canine hearts. J Mol Cell Cardiol (2008) 1.20

Contrast-enhanced MRI of an early preosseous lesion of fibrodysplasia ossificans progressiva in a 21-month-old boy. AJR Am J Roentgenol (2003) 1.19

Posterior reversible encephalopathy syndrome in children with kidney diseases. Pediatr Nephrol (2011) 1.18

Japan Renal Biopsy Registry and Japan Kidney Disease Registry: Committee Report for 2009 and 2010. Clin Exp Nephrol (2013) 1.17

Congenital joint dislocations caused by carbohydrate sulfotransferase 3 deficiency in recessive Larsen syndrome and humero-spinal dysostosis. Am J Hum Genet (2008) 1.15

Elevation of serum Krebs von den Lunge-6 levels in patients with tubulointerstitial nephritis and uveitis syndrome. Am J Kidney Dis (2006) 1.14

Pseudoachondroplasia and multiple epiphyseal dysplasia: a 7-year comprehensive analysis of the known disease genes identify novel and recurrent mutations and provides an accurate assessment of their relative contribution. Hum Mutat (2011) 1.13

The 1998 report of the Japanese National Registry data on pediatric end-stage renal disease patients. Pediatr Nephrol (2002) 1.13

Whole-exome sequencing identifies mutations of KIF22 in spondyloepimetaphyseal dysplasia with joint laxity, leptodactylic type. Am J Hum Genet (2011) 1.13

A recurrent mutation in type II collagen gene causes Legg-Calvé-Perthes disease in a Japanese family. Hum Genet (2007) 1.13

Large fontanelles are a shared feature of haploinsufficiency of RUNX2 and its co-activator CBFB. Congenit Anom (Kyoto) (2004) 1.12

Prenatal diagnosis of hypochondrogenesis using fetal MRI: a case report. Pediatr Radiol (2002) 1.11

Mutations in B3GALT6, which encodes a glycosaminoglycan linker region enzyme, cause a spectrum of skeletal and connective tissue disorders. Am J Hum Genet (2013) 1.11

Creatinine-based equation to estimate the glomerular filtration rate in Japanese children and adolescents with chronic kidney disease. Clin Exp Nephrol (2013) 1.10

The ACVR1 617G>A mutation is also recurrent in three Japanese patients with fibrodysplasia ossificans progressiva. J Hum Genet (2007) 1.10

Segmental and full paternal isodisomy for chromosome 14 in three patients: narrowing the critical region and implication for the clinical features. Am J Med Genet A (2005) 1.10

IL-18 neutralization ameliorates obstruction-induced epithelial-mesenchymal transition and renal fibrosis. Kidney Int (2009) 1.10

The impact of repeated subclinical acute rejection on the progression of chronic allograft nephropathy. J Am Soc Nephrol (2003) 1.09

Japan Renal Biopsy Registry: the first nationwide, web-based, and prospective registry system of renal biopsies in Japan. Clin Exp Nephrol (2011) 1.08

Cytochrome P450 oxidoreductase deficiency: identification and characterization of biallelic mutations and genotype-phenotype correlations in 35 Japanese patients. J Clin Endocrinol Metab (2009) 1.08

Novel SBDS mutations caused by gene conversion in Japanese patients with Shwachman-Diamond syndrome. Hum Genet (2004) 1.08

Analysis of NPHS1, NPHS2, ACTN4, and WT1 in Japanese patients with congenital nephrotic syndrome. Kidney Int (2005) 1.07

Membranoproliferative glomerulonephritis in a patient with X-linked agammaglobulinemia. Pediatr Nephrol (2005) 1.07

Relative frequency of underlying genetic causes for the development of UPD(14)pat-like phenotype. Eur J Hum Genet (2012) 1.07

Hepatocellular carcinoma with extensive peliotic change. J Hepatobiliary Pancreat Surg (2009) 1.07

Decreased abundance of urinary exosomal aquaporin-1 in renal ischemia-reperfusion injury. Am J Physiol Renal Physiol (2009) 1.06

FAM111A mutations result in hypoparathyroidism and impaired skeletal development. Am J Hum Genet (2013) 1.06

Glutamate mediates platelet activation through the AMPA receptor. J Exp Med (2008) 1.04

Combination therapy with mizoribine for severe childhood IgA nephropathy: a pilot study. Pediatr Nephrol (2008) 1.04

Antenatal three-dimensional sonographic features of Roberts syndrome. Arch Gynecol Obstet (2011) 1.03

Osteogenesis imperfecta type V: clinical and radiographic manifestations in mutation confirmed patients. Am J Med Genet A (2013) 1.03

Whole-exome sequencing detects somatic mutations of IDH1 in metaphyseal chondromatosis with D-2-hydroxyglutaric aciduria (MC-HGA). Am J Med Genet A (2011) 1.02

Novel and recurrent mutations clustered in the von Willebrand factor A domain of MATN3 in multiple epiphyseal dysplasia. Hum Mutat (2004) 1.02